pjmedia.com By Ben Bartee
Let’s assume that the FDA regulators practiced real science without fear or favor in the public interest.
Why would the pharmaceutical industry stocks tank when one of them is forced to exit?
They would presumably be replaced with an equally honest broker who would continue the longstanding practice of honest science in the public interest.
Furthermore, why would industry actors describe that fired bureaucrat — who, again, ostensibly regulates their behavior, whose interests are totally unaligned with theirs — as an “ally”?
Via Children’s Health Defense (emphasis added):
Pharma stocks tumbled today after Peter Marks, M.D., Ph.D., director of the agency within the U.S. Food and Drug Administration (FDA) responsible for authorizing vaccines, resigned under pressure from his new boss, Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.
“If Peter Marks does not want to get behind restoring science to its golden standard and promoting radical transparency, then he has no place at FDA under the strong leadership of Secretary Kennedy,” an HHS official said in a statement.
Shares of Moderna, BioNTech, Novavax and Pfizer declined 11%, 7%, 6% and 2%, respectively, on the news, Fast Company reported. STAT News reported that Marks’ departure “is a worst-case scenario realized” for investors and “a biopharma industry that saw him as an ally.”
It’s all well and good that RFK Jr. is purging these people from the ranks of the FDA, CDC, et al…
READ FULL ARTICLE HERE… (pjmedia.com)
Home | Caravan to Midnight (zutalk.com)
